Price, familiarity, and availability determine the choice of drug - a population-based survey five years after generic substitution was introduced in Finland

BMC Clinical Pharmacology

Volumn 11, Issue , 2011, Pages

  Heikkilä, Reeta ^a   Mäntyselkä, Pekka ^a,b   Ahonen, Riitta ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTUMN; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG CHOICE; DRUG COST; DRUG PACKAGING; FEMALE; FINLAND; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICINE; PRESCRIPTION; QUESTIONNAIRE; RANDOM SAMPLE; STATISTICAL ANALYSIS; TABLET; ADOLESCENT; ATTITUDE TO HEALTH; COMMERCIAL PHENOMENA; DECISION MAKING; DRUG SUBSTITUTION; ECONOMICS; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

GENERIC DRUG; PRESCRIPTION DRUG;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHOICE BEHAVIOR; COMMERCE; DRUG COSTS; DRUG SUBSTITUTION; DRUGS, GENERIC; FEMALE; FINLAND; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PRESCRIPTION DRUGS; QUESTIONNAIRES; YOUNG ADULT;

EID: 83455162856     PISSN: None     EISSN: 14726904     Source Type: Journal    
DOI: 10.1186/1472-6904-11-20     Document Type: Article

References (22)

1. Finnish Medical Association Lausunto luonnoksesta hallituksen esitykseksi eduskunnalle lääkelain ja sairausvakuutuslain muuttamiseksi. Statement for the Ministry of Social Affairs and Health 2002, [in Finnish], Finnish Medical Association.
2. Pharma Industry Finland Lausunto luonnoksesta lakiehdotukseksi geneerisen substituution toteuttamiseksi Suomessa. Statement for the Ministry of Social Affairs and Health 2002, [in Finnish], Pharma Industry Finland.
3. Gore P, Madhavan S, McClung G, Riley D. Consumer involvement in nonprescription medicine purchase decisions. J Health Care Mark 1994, 14:16-23.
4. Hanna LA, Hughes CM. Public's views on making decisions about over-the-counter medication and their attitudes towards evidence of effectiveness: A cross-sectional questionnaire study. Patient Educ Couns 2011, 83:345-351. 10.1016/j.pec.2011.02.016, 21440405.
5. Wazaify M, Shields E, Hughes CM, McElnay JC. Societal perspectives on over-the-counter (OTC) medicines. Fam Pract 2005, 22:170-176. 10.1093/fampra/cmh723, 15710640.
6. The Proprietary Association of Great Britain A Summary Profile of the OTC Consumer 2005, London, The Proprietary Association of Great Britain.
7. Andersen ML, Laursen K, Schaumann M, Rubak SL, Olesgaard P, Mainz J, Lauritzen T. How do patients evaluate the newly introduced system of substituting prescriptions?. Ugeskr Laeger 2000, 162:6066-6069. [in Danish].
8. Rubak SL, Andersen ML, Mainz J, Olesgaard P, Lauritzen T. How do practitioners evaluate the newly introduced system of substituting prescriptions?. Ugeskr Laeger 2000, 162:6070-6073. [in Danish].
9. Rubak SL, Andersen ML, Mainz J, Olesgaard P, Laursen K, Schaumann M, Lauritzen T. How do pharmacists evaluate the newly introduced system of substituting prescriptions?. Ugeskr Laeger 2000, 162:6074-6077. [in Danish].
10. Socialstyrelsen Patientsäkerhet vid utbyte av läkemedel på apotek 2004, Stockholm, [in Swedish], Socialstyrelsen.
11. Frisk P, Rydberg T, Carlsten A, Ekedahl A. Patients' experiences with generic substitution: a Swedish pharmacy survey. Journal of Pharmaceutical Health Services Research 2011, 2:9-15.
12. Gill L, Helkkula A, Cobelli N, White L. How do customers and pharmacists experience generic substitution?. International journal of pharmaceutical and healthcare marketing 2010, 4:375-395.
13. Håkonsen H, Toverud EL. Special challenges for drug adherence following generic substitution in Pakistani immigrants living in Norway. Eur J Clin Pharmacol 2011, 67:193-201. 10.1007/s00228-010-0960-9, 3021708, 21161197.
14. Toverud EL, Roise AK, Hogstad G, Wabo I. Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences. Eur J Clin Pharmacol 2011, 67:33-38. 3016237, 21104408.
15. Sorensen L, Stokes JA, Purdie DM, Woodward M, Roberts MS. Medication management at home: medication risk factor prevalence and inter-relationships. J Clin Pharm Ther 2006, 31:485-491. 10.1111/j.1365-2710.2006.00768.x, 16958827.
16. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Generic substitution of antihypertensive drugs: does it affect adherence?. Ann Pharmacother 2006, 40:15-20.
17. Heikkilä R, Mäntyselkä P, Hartikainen-Herranen K, Ahonen R. Customers' and physicians' opinions of and experiences with generic substitution during the first year in Finland. Health Policy 2007, 82:366-374. 10.1016/j.healthpol.2006.10.006, 17141355.
18. Heikkilä R, Mäntyselkä P, Ahonen R. Do people regard cheaper medicines effective? Population survey on public opinion of generic substitution in Finland. Pharmacoepidemiol Drug Saf 2011, 20:185-191. 10.1002/pds.2084, 21254290.
19. Lahnajärvi L, Klaukka T, Enlund H. Ahvenanmaa - itsehallittua lääkekulutusta. 1997, Helsinki: Kansaneläkelaitos.
20. Ylinen S, Hameen-Anttila K, Sepponen K, Lindblad AK, Ahonen R. The use of prescription medicines and self-medication among children-a population-based study in Finland. Pharmacoepidemiol Drug Saf 2010, 19:1000-1008. 10.1002/pds.1963, 20712023.
21. Turunen JH, Mäntyselkä PT, Kumpusalo EA, Ahonen RS. Frequent analgesic use at population level: prevalence and patterns of use. Pain 2005, 115:374-381. 10.1016/j.pain.2005.03.013, 15911164.
22. Pohjanoksa-Mäntylä M, Bell JS, Helakorpi S, Närhi U, Pelkonen A, Airaksinen MS. Is the Internet replacing health professionals? A population survey on sources of medicines information among people with mental disorders. Soc Psychiatry Psychiatr Epidemiol 2011, 46:373-379. 10.1007/s00127-010-0201-7, 20225134.